Effects of prostaglandin E2 and all-trans retinoic acid combination on induced differentiation of human acute promyelocytic leukemia NB4 cells

Chinese Medical Journal

Volumn 110, Issue 10, 1997, Pages 783-788

  Chen, Zixing ^a   Breitman, Theodore R ^b  

^a The First Affiliated Hospital   (China)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTAGLANDIN E2; RETINOIC ACID; ANTINEOPLASTIC AGENT;

ACUTE MYELOBLASTIC LEUKEMIA; ARTICLE; CANCER CELL CULTURE; CELL DIFFERENTIATION; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; CELL CULTURE; PATHOLOGY; PROMYELOCYTIC LEUKEMIA;

ANTINEOPLASTIC AGENTS; CELL DIFFERENTIATION; DINOPROSTONE; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 0031244122     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Huang ME, Ye TC, Chen SR, et al. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 1988 ; 72 : 567.
2. Warrell RP Jr, Frankel SR, Miller WH Jr. et al. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans retinoic acid). N Engl J Med 1991 ; 324 : 1385.
3. Chen ZX, Xue YQ, Zhang R, et al. A clinical and experimental study on all-trans retinoic acid-treated acute promyelocytic leukemia patients. Blood 1991 ; 78 : 1413.
4. Muindi J, Frankel SR, Miller WH Jr, et al. Continuous treatment with all-trans retinoic acid causes a progressive reduction in plasma drug concentrations; implications for relapse and retinoic "resistance " in patients with acute promyelocytic leukemia. Blood 1992; 79 : 299.
5. Delva L, Cornic M, Balitrand N, et al. Resistance to all-trans retinoic acid (ATRA) therapy in relapsing acute promyelocytic leukemia : study of in Vitro ATRA sensitivity and cellular retinoic acid binding protein levels in leukemic cells. Blood 1993; 82 : 2175.
6. Cornic M, Delva L, Guidez F, et al. Induction of retinoic acid-binding protein in normal and malignant human myeloid cells by retinoic acid in acute promyelocytic leukemia patients. Canc Res 1992; 52 : 3329.
7. Breitman TR and Keene BR. Growth and differentiation of the human promyelocytic cell line, HL-60, in a deined medium. In : DA Sirbasku, GH Sato and AB Pardee, eds. Growth of Cells in Hormonally Defined Media. Cold Spring Harbor Conferences on Cell Proliferation, 9. New York: Cold Spring Harbor Laboratory Press, 1982 : 691.
8. Breitman TR and He RY. Combinations of retinoic acid with either sodium butyrate, dimethyl sulfoxide, or hexamethylene bisacetamide Synergistically induce differentiation of the human myeloid leukemia cell line HL60. Canc Res 1990; 50 : 6268.
9. Olsson IL, Breitman TR, and Gallo RC. Priming og human myeloid leukemic cell lines HL-60 and U-937 with retinoic acid for differentiation effects of cyclic adenosine 3′ : 5′-monophosphate-inducing agents and a T-lymphocyte-derived differentiation factor. Canc Res 1982; 42 : 3928.
10. Chen ZX and Breitman TR : Tributyrin, a prodrug of butyric acid for potential clinical application in differentiation therapy. Canc Res 1994; 54 : 34.
11. Castaigne S, Balitrand N, de The H, et al. A PML/ retinoic acid receptor α fusion transcript is constantly detected by RNA-based polymerase chain reaction in acute promyelocytic leukemia. Blood 1992; 79 : 3110.
12. Breitman TR. Growth and differentiation of human myeloid leukemia cell line HL-60. Methods Enzymol 1990; 190 : 118.
13. Breitman TR, Keene BR and Hemmi H. Retinoic acid-induced differentiation of fresh human leukemia cells and the human myelomonocytic leukemia cell lines, HL-60, U-937, and THP-1. Cancer Surveys 1983; 2(2) : 263.
14. Peyron R, Aubeny E, Targosz V, et al. Early termination of pregnancy with mifepristone (RU 486) and the orallyactive prostaglandin misoprostol. N Engl J Med 1993; 328(21) : 1509.
15. 2 prevents gut atrophy during intraveneous feeding but not bacterial translocation. Arch Surg 1993; 128 : 178.
16. 1 derivative, on platelet function. Thromb Res 1991; 63 : 29.
17. 2 adminstration in infants with ductus-dependent cyanotic congenital heart disease. Eur J Pediatr 1987; 146 : 279.
18. 2 in ductus-dependent pulmonary circulation. Circulation 1981; 63 : 682.
19. 2 tablets used for induction of labour. Prostaglandins 1977; 13(3) : 399.